Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants
- 5 September 2018
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 14 (12) , 2971-2978
Abstract
Pregnant women are risk group for influenza infection. Results of new subunit vaccines application have not been studied enough. Prospective, randomized, open-label comparative study of subunit (Agrippal) and polymeric subunit (Grippol plus) vaccines. 42 pairs of mothers-infants were participated in the study. Protective antibodies (≥ 1:40) to different influenza strains were registered on day 1 after the birth on the same level as 53% of cases in pairs mothers-infants after immune adjuvant polymeric subunit and subunit vaccines administration. There were the same level of protective antibodies (AB) among mothers after 3 month, but transplacental antibodies decreased among infants and registered in the 13–22% cases of Grippol plus group and 31–43% cases in Agrippal S1 group. AB titre to influenza virus A/H1N1/pdm09 and A/H3N2/in pairs mothers-infants were the same in both groups in first days after birth, but AB levels to B strain were lower among infants without regard to vaccine. There is no difference in AB titres among infants of both groups at 3 month of age, but their levels were twice lower versus initial data. An immune adjuvant polymeric subunit as well as subunit vaccines application in pregnant women forms protective AB in pairs mothers-infants.Keywords
This publication has 15 references indexed in Scilit:
- VACCINE-CHALLENGED IMMUNE RESISTANCE TOWARD VIRUS A/CALIFORNIA/7/2009(H1N1)v IN IMMUNIZED PREGNANT WOMENMedical Immunology (Russia), 2014
- [Vaccination against influenza A (H1N1) in pregnancy].2011
- Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young InfantsArchives of Pediatrics & Adolescent Medicine, 2011
- Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their InfantsClinical Infectious Diseases, 2010
- Influenza Immunization in Pregnancy — Antibody Responses in Mothers and InfantsNew England Journal of Medicine, 2010
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 AdjuvantThe Pediatric Infectious Disease Journal, 2009
- Response of Influenza Vaccines Against Heterovariant Influenza Virus Strains in Adults with Chronic DiseasesJournal of Clinical Immunology, 2007
- MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complicationsVaccine, 2007
- Study of interaction between the polyoxidonium immunomodulator and the human immune system cellsInternational Immunopharmacology, 2004
- Protection of Infants from Infection with Influenza A Virus by Transplacentally Acquired AntibodyThe Journal of Infectious Diseases, 1980